Del HC: Evidence in Predicate Offence by Accused Who Becomes Approver Can’t be Used in PMLA Procee.  ||  Del. HC: Order Passed in Favour of Indian Hotels Company Over Use of ‘Ginger’ Trademark  ||  Supreme Court: Notice Issued to IBBI Over Ambiguity in Uploading NCLT Orders  ||  SC: It is Up to the Arbitral Tribunal to Adjudicate Upon Construction of Terms of Contract  ||  Supreme Court: Replication to WS Can be Filed by Election Petitioner if New Facts Not Introduced  ||  Del. HC: Convict Can’t Seek Parole for Maint. Conjugal Relat. With Live-in Partner When Wife Present  ||  Delhi High Court: Parties Must Not Ordinarily Resort to Transfer of Case to Another Court  ||  Status Quo Ordered by SC on Felling of Trees in Ridge/Reserve Forest, Contempt Notice Issued  ||  SC: Presiding Officers/Members of JJ Board Should Specifically Mention Names in Orders  ||  Open Air Prisons Suggested by Supreme Court as Solution to Overcrowding of Prisons    

Monitoring of Investments in Alternative Investment Fund (AIF)- (Insurance Regulatory and Development Authority) (28 Jul 2023)

MANU/IRDA/0048/2023

Insurance

The Authority vide its circular IRDA/F&I/ClR/INV/172/08/2013 dtd.23rd August,2013 had permitted insurers for investments in Category I and II AIFs (within SEBI Regulations) as a part of "Other Investments".

With a view to closely monitor the exposure of insurers to AIFs, it is hereby advised that the insurers shall adhere the following requirements with respect to investments in AlFs:

1. The NAVs of AIFs should be declared on quarterly basis.

2. The rollover of investments in AlFs should be approved by the Board/Investment Committee.

3. The insurers shall submit a quarterly return for investments in AIFs as per the format specified in Annexure-I within 15 days from the end of each quarter.

All insurers are required to ensure compliance.

Tags : MONITORING   INVESTMENTS   AIF  

Share :        
With a view to closely monitor the exposure of insurers to AIFs, it is hereby advi... For read more news from newsroom.manupatra.com"data-action="share/whatsapp/share" class="ic_wtsp-grid">

Disclaimer | Copyright 2024 - All Rights Reserved